Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $334,222 (100.0% shares, 0.0% debt)

Holdings (5)

MRNA Moderna Inc 57.6%

Value ($000) $192,605 Shares 4,632,149 Est. Cost $16.43 Unrealized +190.8%

FHTX Foghorn Therapeutics Inc 17.9%

Value ($000) $59,822 Shares 12,674,120 Est. Cost $19.16 Unrealized -62.0%

SANA Sana Biotechnology Inc 12.2%

Value ($000) $40,753 Shares 25,001,856 Est. Cost $32.56 Unrealized -90.8%

— Omega Therapeutics Inc 6.5%

Value ($000) $21,791 Shares 29,225,579 Est. Cost $17.39 Unrealized —

— Seres Therapeutics Inc 5.8%

Value ($000) $19,252 Shares 23,117,045 Est. Cost $7.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	4,632,149	$192,605	57.6%	$16.43	+190.8%	COM	60770K107
FHTX	Foghorn Therapeutics Inc	12,674,120	$59,822	17.9%	$19.16	-62.0%	COM	344174107
SANA	Sana Biotechnology Inc	25,001,856	$40,753	12.2%	$32.56	-90.8%	COM	799566104
—	Omega Therapeutics Inc	29,225,579	$21,791	6.5%	$17.39	—	COM	68217N105
—	Seres Therapeutics Inc	23,117,045	$19,252	5.8%	$7.75	—	COM	81750R102